Insiders Updates
Examining the Potential Price Growth of Larimar Therapeutics Inc (LRMR)
In a filing, Larimar Therapeutics Inc revealed its Director Flynn James E acquired Company’s shares for reported $30.0 million on
Menu
In a filing, Larimar Therapeutics Inc revealed its Director Flynn James E acquired Company’s shares for reported $30.0 million on
Larimar Therapeutics Inc’s recent filing unveils that its Director Flynn James E acquired Company’s shares for reported $30.0 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Larimar Therapeutics Inc’s filing revealed that its Director Flynn James E acquired Company’s shares for reported $30.0 million on Jul
Larimar Therapeutics Inc’s filing revealed that its Director Flynn James E acquired Company’s shares for reported $30.0 million on Jul
Larimar Therapeutics Inc’s filing revealed that its Director Flynn James E acquired Company’s shares for reported $30.0 million on Jul
In a filing, Larimar Therapeutics Inc revealed its Director Flynn James E acquired Company’s shares for reported $30.0 million on
Larimar Therapeutics Inc’s filing revealed that its Director Flynn James E acquired Company’s shares for reported $30.0 million on Jul
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Larimar Therapeutics Inc’s recent filing unveils that its Director Flynn James E acquired Company’s shares for reported $30.0 million on